Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer

NCT00093808 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: capecitabine
DRUG: vinorelbine tartrate

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]